BrickmanA. S.SherrardD. J.JowseyJ.SingerF. R.BaylinkD. J.MaloneyN.MassryS. G.NormanA. W.CoburnJ. W.: 1.25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy. Arch. intern. Med.134 (1974), 883.
2.
CohenM. E. L.CohenG. F.AhadV.KayeM.: Renal osteodystrophy in patients on chronic haemodialysis. A radiological study. Clin. Radiol.21 (1970), 124.
3.
DavieM. J. W.ChalmersT. M.HunterJ. O.PelcB.KodicekE.: 1-alpha-hydroxycholecalciferol in chronic renal failure. Studies of the effect of oral doses. Ann. intern. Med.84 (1976), 281.
4.
DequekerJ.: Quantitative radiology: Radiogrammetry of cortical bone. Brit. J. Radiol.49 (1976), 912.
5.
GarnS. M.PoznanskiA. K.NagyJ. M.: Bone measurement in the differential diagnosis of osteopenia and osteoporosis. Radiology100 (1971), 509.
6.
GenantH. K.KozinF.BebermanG.: The reflex sympathetic dystrophy syndrome. Radiology117 (1975), 21.
7.
HendersonR. G.KanisJ. A.LedinghamJ. G. G.OliverD. O.RussellR. G. G.SmithR.WaltonR. J.: Comparative effect of 1α-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophy. In:Proceedings of the XIth European Symposium on Calcified Tissues, p. 221. F.A.D.L. Publishing Company, Copenhagen1975.
8.
HolicM. F.SemmlerE. J.SchnoesH. K.De LucaH. F.: 1α-hydroxy derivative of vitamin D3: A highly potent analog of 1α, 25-dihydroxy vitamin D3. Science180 (1973), 190.
9.
JohannsenA.NielsenH. E.HansenH. E.: Bone maturation in children with chronic renal failure. Effect of 1α-hydroxy vitamin D3 and renal transplantation. Acta radiol. Diagnosis20 (1979), 193.
10.
JohnsonC.GrahamC. B.CurtisF. K.: Roentgenographic manifestations of chronic renal disease treated by periodic hemodialysis. Amer. J. Roentgenol.101 (1967), 915.
11.
JunorB. J. R.CattoG. R. D.MacLeodM.PapaoulosS. E.O'RiordanJ. L. H.FraserR. A.: 1-alpha-hydroxycholecalciferol in the treatment of renal osteodystrophy. In:Proceedings of the Thirteenth Congress of the European Dialysis and Transplant Association, p. 424. Edited by RobinsonB. H. B.. Pitman Publishing Company, England1976.
12.
MawerE. B.BackhouseJ.TaylorC. M.LumbG. A.StanburyS. W.: Failure of formation of 1.25-dihydroxycholecalciferol in chronic renal insufficiency. LancetI (1973), 626.
13.
MeemaH. E.OreopoulosD. G.MeemaS.: A roentgenologic study of cortical bone resorption in chronic renal failure. Radiology126 (1978), 67.
NielsenH. E.MelsenF.ChristensenM. S.HansenH. E.RødbroP.JohannsenA.: 1α-hydroxycholecalciferol treatment of long-term hemodialyzed patients. Effects on mineral metabolism, bone mineral content and bone morphometry. Clin. Nephrol.8 (1977), 429.
16.
NielsenS. P.BinderupE.GodtfredsenW. O.JensenH.LadefogedJ.: 1α-hydroxycholecalciferol. Long-term treatment of patients with uraemic osteodystrophy. Nephron16 (1976), 359.
17.
PieridesA. M.EllisH. A.SimpsonW.DewarJ. H.WardM. K.KerrD. N. S.: Variable response to long-term 1α-hydroxycholecalciferol in haemodialysis osteodystrophy. LancetI (1976), 1092.
18.
ResnickD.NiwayamaG.: Subchondral resorption of bone in renal osteodystrophy. Radiology118 (1976), 315.
19.
WellerM.EdeikenJ.HodesP. J.: Renal osteodystrophy. Amer. J. Roentgenol.104 (1968), 354.